Results 151 to 160 of about 7,788 (192)

Bilateral Choroidal Metastases Mimicking Central Serous Chorioretinopathy: A Diagnostic Challenge. [PDF]

open access: yesCureus
Murati Calderon RA   +4 more
europepmc   +1 more source

A comprehensive overview: deep learning approaches to central serous chorioretinopathy diagnosis. [PDF]

open access: yesBMC Ophthalmol
Shojaeinia M   +6 more
europepmc   +1 more source

Central Serous Chorioretinopathy and Glucocorticoids

Survey of Ophthalmology, 2002
Central serous chorioretinopathy is a relatively common retinal disease characterized by the accumulation of subretinal fluid at the posterior pole of the fundus, creating a circumscribed area of serous retinal detachment. It typically affects young and middle-aged men with no previous medical and family history, and no systemic symptoms or signs ...
Evrydiki A Bouzas
exaly   +3 more sources

Central Serous Chorioretinopathy and Helicobacter Pylori

European Journal of Ophthalmology, 2006
Purpose This study was designed to evaluate the prevalence of Helicobacter pylori infection in patients with central serous chorioretinopathy (CSC). Methods Retrospective observational case series.
M Borrelli
exaly   +4 more sources

Central Serous Chorioretinopathy

2017
Central serous is an atypical form of macular edema with mostly accumulation of fluid under the retina. It contitutes a pure phenotype of retinal pigment epithelium barrier breakdown. Another particularity is the good visual preservation despite important fluid volume increase in the macula.
Alejandra, Daruich   +2 more
openaire   +3 more sources

Masqueraders of central serous chorioretinopathy

Survey of Ophthalmology, 2019
Central serous chorioretinopathy (CSCR) is one of the most common chorioretinal pathologies affecting middle-aged men worldwide. Although it has a self-limited course, a significant number of patients suffer from chronic and recurrent episodes. This often leaves the patient with various degrees of visual impairment.
Niroj Kumar Sahoo   +4 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy